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What is known about the subject?
 ► There is a dearth of studies on the prevalence and 
stability of interview- based DSM- IV and DSM-5 di-
agnosable insomnia in childhood.
 ► Previous work is characterised by differing estimates 
depending on the definition of sleep difficulties (eg, 
from problems to disorders) and methodological ap-
proach (ie, time- span, informants).
 ► In early adolescence, a female preponderance in the 
prevalence of insomnia is typically reported.
What this study adds?
 ► Both DSM- IV and DSM-5- defined insomnia were 
less prevalent in this study than previous research 
indicates.
 ► Sex differences were apparent with DSM- IV, but not 
DSM-5, criteria: male preponderance at ages 4-10 
years and female preponderance at ages 12 and 14 
years.
 ► Insomnia was moderately to highly stable; those 
with current insomnia (compared with those with-
out) were 5–15 times as likely to have subsequent 
insomnia.
AbstrACt
background There is limited knowledge about the 
prevalence and stability of insomnia defined by the 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM). We therefore provide such estimates from 
preschool to early adolescence and explore potential sex 
differences.
Methods We followed a representative community 
sample (n=1037) biennially from 4 to 14 years of age 
(2007–2017). Insomnia diagnoses and symptoms were 
captured by a semistructured clinical interview of parents 
and children (from age 8 years).
results At ages 4 and 6 years approximately 2.5% of 
children met the criteria for insomnia, whereas at ages 
8, 10, 12 and 14 years the prevalence ranged from 7.5% 
to 12.3%. During the 10- year period examined nearly 1 
in 5 children had insomnia at least once (18.7%). Sex 
differences were apparent with DSM- IV, but not DSM-5, 
criteria: boys (8.1%) had more insomnia than girls (4.5%) 
did at ages 4–10 years, whereas girls (11.4%) had more 
insomnia than boys (7.1%) did at ages 12 and 14 years. 
Insomnia proved stable, with 22.9%–40.1% of children 
retaining their diagnosis 2 years later. Having current 
insomnia produced medium to large ORs of between 5.1 
(95% CI 2.6 to 9.8) and 15.3 (95% CI 4.4 to 52.9) for 
subsequent insomnia 2 years later compared with not 
having preceding insomnia.
Conclusions Insomnia was less prevalent than 
previous research indicates, with nearly 1 in 5 participants 
having insomnia at least once between the ages of 4 
and 14 years. Female preponderance emerged in early 
adolescence. Having insomnia at one time point was a 
considerable risk for subsequent insomnia, indicating that 
insomnia is persistent and warrants clinical attention.
IntroduCtIon
Childhood insomnia is associated with nega-
tive outcomes that include emotional, behav-
ioural and cognitive problems.1–3 Prevalence 
estimates and a description of the course of 
insomnia may aid preventative and treatment 
efforts. However, most previous research on 
this topic in children has examined insomnia 
symptoms4–11 that may not have the severity, 
duration, intensity or associated impairment 
that warrants a clinical diagnosis. Moreover, 
research has almost exclusively relied on 
questionnaires/checklists,12–14 with various 
biases.15 In clinical interviews, on the other 
hand, the interviewer probes until it is 
clear whether a symptom is present or not 
according to diagnostic criteria.
Only three previous studies have esti-
mated the prevalence of childhood 
insomnia through clinical interviews,16–18 
two addressing early childhood16 17 and one 
reporting averaged rates for the age span 
8–18 years.18 In addition, two questionnaire- 
based longitudinal studies have assessed 
insomnia into early adolescence.12 13 Hence, 
there is a dearth of studies on the prevalence 
of diagnosable insomnia from preschool to 
adolescence based on interview data. We will 
therefore provide such estimates.
If, once established, childhood insomnia 
evinces a chronic course, early intervention 
may be warranted. However, if insomnia is 
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transient there is less need to intervene. Preschool- age 
insomnia has been found to increase the risk of later 
insomnia,17 and studies of preadolescents indicate 
that insomnia symptoms are moderately stable.6–8 12 13 
However, these studies used questionnaires and check-
lists; thus, the stability reported may reflect the stability 
of the rater rather than of the symptoms. By using clinical 
interviews, as we do here, rater bias and common method 
biases are reduced and hence more accurate stability esti-
mates can be obtained.
From the fourth edition of the Diagnostic and Statis-
tical Manual of Mental Disorders (DSM- IV)19 to the fifth 
(DSM-5),20 the symptom of experiencing sleep as non- 
restorative has been replaced with that of early morning 
awakenings accompanied by the inability to return to 
sleep. The impact of this change on prevalence estimates 
and course in children is unknown but will be examined 
here.
Using a semistructured clinical interview in a large and 
representative community sample (over six waves, from 
age 4 to 14 years) we tested the following hypotheses: 
(1) the rate of insomnia will decrease from preschool to 
middle childhood and rise again in early adolescence; 
(2) insomnia is more prevalent in girls than in boys in 
early adolescence, as shown earlier regarding insomnia 
symptoms;4 18 21–23 (3) the 2- year persistence of insomnia 
is of medium effect size.
Methods
Procedure and participants
Data came from the Trondheim Early Secure Study 
(TESS).24 All children born in 2003 and 2004 in Trond-
heim (n=3456), Norway, were invited to participate 
through a letter of invitation ahead of an ordinary 
community health check- up at the age of 4 years. Health 
nurses informed parent(s) about the study and obtained 
written consents to participate (82.2% of those invited). 
Included in the letter of invitation was the Strengths and 
Difficulties Questionnaire (SDQ) for 4–16 year- olds,25 
which the parents completed and brought with them 
to the check- up. The SDQ has proven to be an excel-
lent tool in screening for mental health problems in 
preschoolers.26 To increase variability and thus statistical 
power, children with mental health problems were over-
sampled. Children were divided into four strata based on 
their SDQ score: 0–4, 5–8, 9–11 and 12–40. The prob-
ability of being selected increased with increased SDQ 
scores (37%, 48%, 70% and 89% from the respective 
strata). Parents with insufficient proficiency in Norwe-
gian to fill out the SDQ were excluded (n=176) and 166 
parents were missed being asked to participate in the 
study. Of the 2477 eligible families, 1250 were drawn 
and invited (three children with SDQ score >25), 997 
(79.7%) attended at baseline. Details of procedure and 
participation rates are presented in online supplemen-
tary eFigure 1. Mean age in years at initial testing (T1, 
descriptive statistics in online supplementary eTable 1) 
was M
age
=4.59, SD=0.25, and at subsequent assessments 
was as follows: T2: M
age










=14.35, SD=0.16. In all, we had diag-
nostic information on at least one time point for 1037 
participants, thus forming the analytical sample. To 
examine attrition at each time point, attrition (ie, not 
attending) was regressed on every study variable on 
the preceding time points. None of the study variables 
predicted attrition, except that boys had higher attrition 
at 10 (OR=1.39, 95% CI 1.07 to 1.81), 12 (OR=1.31, 95% 
CI 1.01 to 1.69) and 14 years of age (OR=1.40, 95% CI 
1.09 to 1.80). The proxy R2 values for sex were all <1%.
Participant and public involvement
The planning, implementation, carry through and 
dissemination from TESS is guided by a user group 
consisting of participating adolescents and parents, 
researchers from TESS, St Olavs Hospital, the munic-
ipal education officer in Trondheim, the youth division 
of the user group Mental Health Norway and Depart-
ment of Education—Trøndelag county. Patients and/or 
the public were involved in the design, or conduct, or 
reporting, or dissemination plans of this research. Refer 
to the Methods section for further details.
Measures
At ages 4 and 6 years, DSM- IV- defined insomnia was 
measured by the Preschool Age Psychiatric Assessment 
(PAPA),27 a parent interview that follows a structured 
protocol. PAPA is a revised version of the Child and 
Adolescent Psychiatric Assessment (CAPA), which is 
appropriate for older children and hence was used in this 
study when the children were 8, 10, 12 and 14 years of 
age.28 Children and parents were interviewed separately 
and the interview questions are presented in online 
supplementary file 3. Symptoms of insomnia were consid-
ered present if reported by either parent or child.
The interviewers (n=7) had at least a bachelor’s degree 
in a relevant field and extensive prior experience working 
with children and families. Blinded raters recoded 9% 
of audio- recorded interviews and inter- rater reliability 
between multiple raters for insomnia was k=0.75.
Diagnosing insomnia
According to the DSM- IV,19 the International Classifi-
cation of Sleep Disorders-3 (ICSD-3)29 and the Inter-
national Classification of Diseases, 10th Revision,30 
insomnia is characterised by difficulties initiating and/
or maintaining sleep and/or a subjective experience of 
non- restorative sleep despite adequate opportunities for 
sleep, which lasts for a considerable amount of time and 
causes clinically significant distress or impairment in 
important areas of functioning. However, in the absence 
of a cut- off for the frequency or duration of insomnia 
symptoms, epidemiological research on insomnia has 
been challenging. As no child- specific insomnia criteria 
exist in the DSM, we relied on normative sleep latency, 
by copyright.
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Table 1 Prevalence, incidence and recurrence (%) of DSM- IV and DSM-5- defined insomnia (n=1037)
Age
(years)
DSM- IV insomnia (95% CI) DSM-5 insomnia (95% CI)
Prevalence Incidence Recurrence Prevalence Incidence Recurrence
4 2.6% (1.6% to 3.5%) 2.6% (1.6% to 3.5%) n/a –
6 2.4% (1.4% to 3.5%) 1.7% (0.9% to 2.6%) n/a –
8* 8.3% (6.2% to 10.5%) 6.2% (4.3% to 8.1%) 0.3% (0.0% to 0.6%) –
10 10.2% (7.8% to 12.6%) 6.5% (4.4% to 8.6%) 0.7% (0.0% to 1.3%) 12.3% (9.5% to 15.2%) 7.7% (5.3% to 10.1%) 0.7% (0.0% to 1.4%)
12 7.9% (5.6% to 10.1%) 2.3% (0.9% to 3.6%) 1.2% (0.3% to 2.2%) 7.5% (5.3% to 9.8%) 1.6% (0.5% to 2.6%) 1.1% (0.2% to 2.0%)
14 10.5% (7.8% to 13.1%) 4.9% (3.0% to 6.8%) 1.4% (0.3% to 2.6%) 10.5% (7.5% to 13.4%) 3.7% (1.8% to 5.5%) 1.1% (0.0% to 2.1%)
These estimates are population- corrected estimates. Ages 4–6 years, parent report; ages 8–14, joint report. Incidence estimates represent current insomnia cases with no history of 
insomnia. Recurrence estimates are current insomnia cases without insomnia at the preceding time point, but a history of insomnia prior to the previous time point. DSM-5 incidence 
at age 10 years and recurrence at ages 10–14 years are based on DSM- IV data on time points without DSM-5 data (ages 4–8 years).
*Proxy measure of insomnia—thresholds of 1- hour sleep latency/time awake at night.
DSM, Diagnostic and Statistical Manual of Mental Disorders; n/a, not available.
night awakenings and sleep duration in childhood.10 31–34 
Our data allowed assessing DSM- IV insomnia from 
age 4 to 14 years and DSM-5 insomnia from age 10 to 
14 years. From age 10 years prevalence estimates for 
DSM- IV and DSM-5 insomnia were analysed in parallel. 
DSM- IV insomnia at 4 and 6 years of age was classified 
as preschool insomnia, at ages 8–10 and 12–14 years 
as middle childhood insomnia and early adolescence 
insomnia, respectively.
DSM-IV insomnia
Based on these studies and the DSM- IV criteria with 
suggested cut- offs, we defined DSM- IV insomnia as: (1) 
≥30 min to fall asleep or the use of sleep medication; (2) 
≥20 min awake after sleep onset; or (3) non- restorative 
sleep (insufficiently rested after sleep). The symptom(s) 
had to have occurred at least three times a week and had 
to be present over the previous 3 months, as this is the 
inquiry period of PAPA and CAPA, and be accompanied 
by reports of clinically significant distress or impairment 
in important areas of functioning. Because CAPA probes 
sleep onset or night awakenings in hours rather than 
minutes, it should be noted that we used ≥1 hour as the 
cut- off at age 8 years before correcting this by expanding 
the insomnia interview from age 10 years onwards to 
include time in minutes too. Hence, data from age 8 
years should be viewed as yielding a conservative, proxy 
insomnia measure.
DSM-5 insomnia
In recent years both the DSM-520 and the ICSD-329 
have suggested cut- offs for subjective sleep latency and 
time awake after sleep onset of greater than 20–30 min. 
The DSM-5 parts with DSM- IV criteria regarding non- 
restorative sleep, replacing it with early morning awak-
ening before 8 hours of sleep and being unable to return 
to sleep. In addition, DSM-5 acknowledges that symp-
toms of sleep latency and nocturnal awakenings may be 
masked by caregiver intervention. We therefore regarded 
always relying on parental help to initiate or maintain 
sleep as validation of these symptoms.
statistical analyses
All analyses were performed in Mplus V.8.35 We used 
a full information maximum likelihood approach to 
handle missing data,36 which uses all available data 
to estimate the most likely values for the population 
parameters in the model. As the sample was screen strat-
ified, probability weights where the number of children 
in the stratum was divided by the number of partici-
pants in the same stratum were calculated to arrive at 
corrected population estimates. A robust maximum 
likelihood estimator was used, which is robust to devi-
ations from normality because it provides corrected 
error terms with respect to oversampling. Some cate-
gorical variables served as both predictor and outcome 
(eg, insomnia at ages 6, 8, 10 and 12 years). Because 
Mplus cannot specify an endogenous variable as cate-
gorical, we performed bivariate regressions to assess the 
stability of insomnia (eg, insomnia at age 6 years was 
regressed on insomnia at age 4 years). To investigate 
both the sex differences in the prevalence of insomnia 
at each time point and the stability between time points, 
we compared a model in which prevalence/stability was 
constrained to be equal in the two sexes with another 
model in which prevalence was freely estimated, using 
Wald tests. Supplementary analyses were performed to 
investigate the growth of parent and child reports of 
insomnia over time. We did latent linear growth curve 
analyses where the slopes reflected yearly mean change 
(M
growth
) in insomnia prevalence (%). The growth was 
allowed to correlate with the intercept, set at age 4 
and 8 years for parent and child analysis, respectively. 
Further, we analysed sex differences in insomnia symp-




Table 1 presents the prevalence, incidence and recur-
rence of DSM- IV and DSM-5- defined insomnia at all 
ages. The prevalence of insomnia increased sharply 
from 6 to 8 years. However, bear in mind that children 
by copyright.
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were not included as informants before the age of 8 
years and separate growth curve analyses for parents 
(M
growth
=−0.05, p=0.56) and children (M
growth
=0.13, 
p=0.49) showed no increase in insomnia prevalence 
with age. Thus, the increase from age 8 years onwards 
might be due to having two sets of informants, as 
opposed to only the parents as informants at earlier 
ages. Close to every fifth child had DSM- IV insomnia 
at one point between 4 and 14 years of age (18.7%, 
95% CI 16.2 to 21.2); 12.8% had insomnia at one time 
point only, 4.1% at two points, 1.5% at three points and 
0.3% at four points.
The prevalence of insomnia for the two sexes is 
displayed in online supplementary eFigure 2. DSM- IV 
insomnia was more common in girls (13.7%, 95% CI 9.6 
to 17.7) than in boys (6.7%, 95% CI 3.5 to 10.0) at the 
age of 14 years (Wald=6.79, df=1, p=0.009), and margin-
ally more common in girls (11.4%, 95% CI 8.2 to 14.6) 
than in boys (7.1%, 95% CI 4.5 to 9.8) when comparing 
the mean prevalence of DSM- IV- defined insomnia in 
early adolescence (ages 12–14 years; Wald=4.02, df=1, 
p=0.045). Additionally, DSM- IV insomnia was more 
common among boys (11.5%, 95% CI 7.9 to 15.1) than 
among girls (5.4%, 95% CI 3.1 to 7.8) at the age of 8 
years (Wald=7.64, df=1, p=0.006), and more common 
among boys (8.1%, 95% CI 6.1 to 10.2) than girls 
(4.5%, 95% CI 3.1 to 5.8) when comparing means for 
insomnia for the two sexes in childhood overall (ages 
4–10 years; Wald=8.98, df=1, p=0.003). No sex differ-
ence in insomnia was found using DSM-5 insomnia 
criteria.
The prevalence of the specific symptoms of DSM- IV 
and DSM-5 insomnia is displayed in table 2. Prolonged 
latency of sleep onset was the most common insomnia 
symptom throughout the study period. The least 
frequent DSM- IV symptom was nocturnal awakenings, 
while none of the participants were troubled with 
the DSM-5 symptom of early morning awakenings. 
Comparing the prevalence of DSM- IV and DSM-5 symp-
toms for the two sexes revealed that the symptom of 
non- restorative sleep (DSM- IV) was more common in 
girls (17.8%) than in boys (8.0%) at the age of 14 years 
(Wald=11.87, df=1, p=0.001).
stability and course
Figures 1 and 2 display the course of DSM- IV and DSM-5 
insomnia. Between 32% and 40% of those with an 
insomnia diagnosis at one time point experienced the 
same disorder 2 years later, participants aged 4–6 years 
being the exception (23%). Table 3 reveals insomnia to 
exhibit a moderate to high 2- year stability, with current 
insomnia increasing the probability of subsequent 
insomnia by 5–15 times compared with not having an 
insomnia disorder at the preceding time point. In addi-
tion, insomnia during preschool years (ages 4–6 years) 
increased the risk of insomnia in middle childhood (ages 
8–10 years), and insomnia in middle childhood predicted 
insomnia in early adolescence (ages 12–14 years).
by copyright.
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Figure 1 Course of DSM- IV insomnia. Numbers in boxes 
are prevalence estimates while numbers outside boxes are 
from pairwise crosstabs (only those present for the two ages 
in question). Number of subjects rounded to closest whole 
number, as they are originally population estimates. DSM- IV, 
Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition.
Figure 2 Course of DSM-5 insomnia. Numbers in boxes 
are prevalence estimates while numbers outside boxes are 
from pairwise crosstabs (only those present for the two ages 
in question). Number of subjects rounded to closest whole 
number, as they are originally population estimates. DSM-5, 
Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition.
Sex- specific analyses showed that DSM- IV insomnia was 
more stable in boys from age 4 to age 6 years than in girls 
(who displayed no stability; Wald=58.81, df=1, p<0.001). 
No other sex differences in stability were found. There 
was no difference in 2- year stability between DSM- IV and 
DSM-5- defined insomnia.
dIsCussIon
Biennial interview- based assessments from age 4 to 14 
years revealed that approximately 2.5% of children met 
the criteria for insomnia diagnosis at 4 and 6 years of 
age, whereas at ages 8, 10, 12 and 14 years the prevalence 
ranged from 7.5% to 12.3%. Insomnia proved to be 
stable; 23%–40% of children had retained their diagnosis 
2 years later and current insomnia increased the proba-
bility of insomnia 2 years later by 5–15 times.
Prevalence of insomnia diagnosis
No previous study has examined the prevalence of diag-
nosable insomnia from preschool to early adolescence. 
The three studies employing semistructured interviews 
that have been carried out reported considerably higher 
prevalence estimates, ranging from 16.6% to 21.2%,16–18 
compared with the present findings. The discrepancy 
may be due to these former studies employing broader 
age ranges18 or using DSM- IV criteria with more liberal 
cut- offs for sleep latency and time awake after sleep 
onset.16 17 Notably though, our estimate of the prevalence 
of insomnia substantially exceeds the rate of children and 
adolescents receiving insomnia diagnoses in primary care 
(0.05%–1.20%),37 38 suggesting that insomnia is underdi-
agnosed in children aged 4–14 years. Given that receiving 
treatment for insomnia usually depends on being diag-
nosed with insomnia, this gap is problematic and might 
indicate that many children who need treatment do not 
receive it.
The increase in insomnia from preschool to middle 
childhood does not match previous research on child-
hood insomnia,12 13 17 18 probably due to our inclusion 
of children as informants from age 8 years and onwards. 
As children grow older, parents may be unaware of their 
offspring’s sleeping difficulties (eg, staying in bed despite 
difficulty falling asleep), thus insomnia prevalence 
research relying on parents only probably underesti-
mates prevalence estimates.
In the current study female preponderance emerged 
in early adolescence, which is in line with the typical 
11–12 years of age reported in the literature.21 22 39 The 
sex difference found with DSM- IV criteria indicating that 
insomnia is more common in boys than in girls in the 
period from 4 to 10 years of age is novel in the insomnia 
literature and should therefore be interpreted cautiously. 
Notably, no sex differences were found with DSM-5 
criteria. This may be due to the observed sex difference 
at age 14 years in non- restorative sleep (DSM- IV), the 
symptom that was replaced by early morning awaken-
ings in the DSM-5 which we found to be non- existent 
and therefore not contributing to a sex difference. The 
absence of early morning awakenings in our study may 
be a consequence of emerging circadian delay in early 
by copyright.
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Ages 4–6 years 15.28 (4.42 to 52.88) n/a
Ages 6–8 years 7.33 (2.57 to 20.96) n/a
Ages 8–10 years 5.05 (2.61 to 9.75) n/a
Ages 10–12 years 9.29 (4.49 to 19.20) 6.24 (2.71 to 14.37)
Ages 12–14 years 7.06 (3.31 to 15.06) 10.50 (4.86 to 22.70)
Preschool to middle childhood 5.18 (2.51 to 10.68) n/a
Middle childhood to early adolescence 4.72 (2.79 to 8.00) n/a
Preschool to early adolescence 1.68 (0.73 to 3.89) n/a
Reference category is those without insomnia which continues to not have insomnia. n/a as data not available, DSM-5 criteria introduced at 
10 years of age.
DSM, Diagnostic and Statistical Manual of Mental Disorders.
adolescence, yet this probably does not explain the 
non- existence at earlier ages. Alternatively, not finding 
any sex differences with DSM-5 criteria may be a conse-
quence of more missing data than with DSM- IV criteria 
(see figures 1 and 2 for numbers) from 10 to 14 years of 
age and thus reduced statistical power in gender- specific 
analyses, although our analytical sample of 1037 with 
the full information maximum likelihood procedure to 
account for missing data tried to compensate somewhat 
for the reduced power.
the course of insomnia
Our results reveal that for approximately 23%–40% of 
children, insomnia is stable over a 2- year span. Thus, 
for most children insomnia is transient. In adults, on 
the other hand, insomnia usually fosters further sleep 
problems through maladaptive coping behaviours (eg, 
daytime naps) and negative beliefs about sleep (eg, exag-
geration of the consequences of the lack of sleep)40 as 
well as conditioning.41 That said, for a subgroup of chil-
dren insomnia is persistent and warrants clinical atten-
tion. Hence, research identifying the characteristics of 
those with persistent insomnia is much needed.
limitations
Aside from the strengths of the current study—including 
entailing a large longitudinal community sample 
followed up biennially for 10 years and administering 
clinical interviews based on formal diagnostic criteria—
there are notable limitations. First, we applied a 3- month 
period for insomnia symptoms as this was the inquired 
period in PAPA and CAPA and might thus have under-
estimated the prevalence of DSM- IV insomnia. This 
underestimation may be especially prominent at 8 years 
of age, with our conservative proxy insomnia diagnosis 
(a 1- hour threshold for sleep latency and night awaken-
ings). Conversely, the lack of possibility to exclude other 
sleep disorders (eg, circadian disorders, sleep- disordered 
breathing) may have led to overestimation of insomnia 
prevalence. Second, as the sample was mainly of Norwe-
gian origin our findings may not apply to more ethnically 
diverse populations or other geographical locations. 
Third, although there are numerous similarities between 
the DSM- IV and DSM-5 criteria, this study applied only 
DSM- IV insomnia data for the whole study period as this 
was the diagnostic manual in use at the start of the study. 
Still, our results from age 10 to 14 years with both diag-
nostic criteria indicate that DSM- IV and DSM-5 insomnia 
criteria do not yield significantly different prevalence or 
stability estimates. Lastly, with regard to the revealed sex 
differences in DSM- IV- defined insomnia at both disorder 
and symptom level, it should be acknowledged that these 
analyses by sex and age led to multiple estimations, which 
increases the risk of false positives.
ConClusIons
The present study is the first to provide age- specific popu-
lation prevalence estimates and chronicle the stability of 
insomnia, from preschool to early adolescence, obtained 
through clinical interviews. DSM- defined insomnia was 
less prevalent (ie, 2.4%–12.3%) than has been indicated 
by previous research. No difference in prevalence or 
stability estimates for insomnia was found using DSM- IV 
versus DSM-5 criteria. Girls had marginally more DSM- IV 
insomnia in early adolescence (ages 12–14 years) than 
did boys, while boys had more insomnia than did girls in 
childhood (ages 4–10 years). Yet no sex differences were 
found using the DSM-5 criteria, probably due to no child 
having the newly added DSM-5 symptom of early morning 
awakenings. Insomnia proved moderately to highly stable, 
as illustrated by results showing that between 23% and 
40% maintained their insomnia disorder over a 2- year 
period, and those with current insomnia (compared with 
those without) were 5–15 times as likely to have subse-
quent insomnia.
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